Cardinal Health, Inc. (0HTG.L)
USD 133.02
(1.66%)
USD 133.02
(1.66%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 1.24 Billion USD | 70.98% |
| 2023 | 727 Million USD | -55.89% |
| 2022 | 1.64 Billion USD | -10.48% |
| 2021 | 1.84 Billion USD | 3.84% |
| 2020 | 1.77 Billion USD | -13.93% |
| 2019 | 2.06 Billion USD | 1534.92% |
| 2018 | 126 Million USD | -94.06% |
| 2017 | 2.12 Billion USD | -13.79% |
| 2016 | 2.45 Billion USD | 13.79% |
| 2015 | 2.16 Billion USD | 14.64% |
| 2014 | 1.88 Billion USD | 89.26% |
| 2013 | 996 Million USD | -44.42% |
| 2012 | 1.79 Billion USD | 18.36% |
| 2011 | 1.51 Billion USD | 15.85% |
| 2010 | 1.3 Billion USD | -30.69% |
| 2009 | 1.88 Billion USD | -11.1% |
| 2008 | 2.12 Billion USD | 54.42% |
| 2007 | 1.37 Billion USD | -30.15% |
| 2006 | 1.96 Billion USD | 11.57% |
| 2005 | 1.76 Billion USD | -24.58% |
| 2004 | 2.33 Billion USD | 4.26% |
| 2003 | 2.24 Billion USD | 22.25% |
| 2002 | 1.83 Billion USD | 23.31% |
| 2001 | 1.48 Billion USD | 18.05% |
| 2000 | 1.25 Billion USD | 23.07% |
| 1999 | 1.02 Billion USD | 116.09% |
| 1998 | 473.7 Million USD | 21.06% |
| 1997 | 391.3 Million USD | 38.76% |
| 1996 | 282 Million USD | 72.27% |
| 1995 | 163.7 Million USD | 90.35% |
| 1994 | 86 Million USD | 45.76% |
| 1993 | 59 Million USD | 24.47% |
| 1992 | 47.4 Million USD | 36.6% |
| 1991 | 34.7 Million USD | 39.92% |
| 1990 | 24.8 Million USD | 36.26% |
| 1989 | 18.2 Million USD | 40.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 482 Million USD | 3542.86% |
| 2024 Q1 | -14 Million USD | -110.22% |
| 2024 Q3 | 601 Million USD | 24.69% |
| 2024 FY | 1.24 Billion USD | 70.98% |
| 2024 Q4 | 532 Million USD | -11.48% |
| 2023 Q4 | 137 Million USD | -76.05% |
| 2023 Q1 | 344 Million USD | 3.3% |
| 2023 FY | 727 Million USD | -55.89% |
| 2023 Q2 | 408 Million USD | 18.6% |
| 2023 Q3 | 572 Million USD | 40.2% |
| 2022 Q1 | 415 Million USD | 156.17% |
| 2022 FY | 1.64 Billion USD | -10.48% |
| 2022 Q4 | 333 Million USD | -28.08% |
| 2022 Q3 | 463 Million USD | 148.74% |
| 2022 Q2 | -950 Million USD | -328.92% |
| 2021 FY | 1.84 Billion USD | 3.84% |
| 2021 Q3 | 473 Million USD | 2.6% |
| 2021 Q2 | 461 Million USD | 173.88% |
| 2021 Q1 | -624 Million USD | -331.11% |
| 2021 Q4 | 162 Million USD | -65.75% |
| 2020 Q1 | -5.26 Billion USD | -1814.66% |
| 2020 FY | 1.77 Billion USD | -13.93% |
| 2020 Q2 | 334 Million USD | 106.34% |
| 2020 Q3 | 562 Million USD | 68.26% |
| 2020 Q4 | 270 Million USD | -51.96% |
| 2019 FY | 2.06 Billion USD | 1534.92% |
| 2019 Q3 | 432 Million USD | -14.29% |
| 2019 Q2 | 504 Million USD | -38.24% |
| 2019 Q1 | 816 Million USD | 175.56% |
| 2019 Q4 | 307 Million USD | -28.94% |
| 2018 Q2 | 399 Million USD | 52.29% |
| 2018 Q4 | -1.08 Billion USD | -297.8% |
| 2018 Q1 | 262 Million USD | -40.32% |
| 2018 Q3 | 546 Million USD | 36.84% |
| 2018 FY | 126 Million USD | -94.06% |
| 2017 FY | 2.12 Billion USD | -13.79% |
| 2017 Q3 | 605 Million USD | 11.62% |
| 2017 Q4 | 439 Million USD | -27.44% |
| 2017 Q2 | 542 Million USD | 1.31% |
| 2017 Q1 | 535 Million USD | -13.71% |
| 2016 Q1 | 620 Million USD | 11.11% |
| 2016 Q2 | 563 Million USD | -9.19% |
| 2016 Q3 | 656 Million USD | 16.52% |
| 2016 Q4 | 620 Million USD | -5.49% |
| 2016 FY | 2.45 Billion USD | 13.79% |
| 2015 Q3 | 591 Million USD | 8.24% |
| 2015 FY | 2.16 Billion USD | 14.64% |
| 2015 Q1 | 466 Million USD | 20.41% |
| 2015 Q2 | 546 Million USD | 17.17% |
| 2015 Q4 | 558 Million USD | -5.58% |
| 2014 FY | 1.88 Billion USD | 89.26% |
| 2014 Q3 | 508 Million USD | -2.12% |
| 2014 Q2 | 519 Million USD | 10.19% |
| 2014 Q4 | 387 Million USD | -23.82% |
| 2014 Q1 | 471 Million USD | 206.56% |
| 2013 FY | 996 Million USD | -44.42% |
| 2013 Q4 | -442 Million USD | -193.05% |
| 2013 Q3 | 475 Million USD | -6.13% |
| 2013 Q2 | 506 Million USD | 10.72% |
| 2013 Q1 | 457 Million USD | 13.4% |
| 2012 FY | 1.79 Billion USD | 18.36% |
| 2012 Q4 | 403 Million USD | -23.47% |
| 2012 Q3 | 526.6 Million USD | 17.2% |
| 2012 Q2 | 449.3 Million USD | 8.97% |
| 2012 Q1 | 412.3 Million USD | 14.88% |
| 2011 Q3 | 447.3 Million USD | 30.07% |
| 2011 Q2 | 343.9 Million USD | -5.5% |
| 2011 FY | 1.51 Billion USD | 15.85% |
| 2011 Q4 | 358.9 Million USD | -19.76% |
| 2011 Q1 | 363.9 Million USD | 8.98% |
| 2010 FY | 1.3 Billion USD | -30.69% |
| 2010 Q2 | 366.8 Million USD | 52.9% |
| 2010 Q4 | 333.9 Million USD | -8.85% |
| 2010 Q3 | 366.3 Million USD | -0.14% |
| 2010 Q1 | 239.9 Million USD | -43.58% |
| 2009 Q4 | 425.2 Million USD | -14.33% |
| 2009 FY | 1.88 Billion USD | -11.1% |
| 2009 Q2 | 537.9 Million USD | 26.18% |
| 2009 Q3 | 496.3 Million USD | -7.73% |
| 2009 Q1 | 426.3 Million USD | -20.42% |
| 2008 Q3 | 576.5 Million USD | 11.04% |
| 2008 Q2 | 519.2 Million USD | 6.0% |
| 2008 Q4 | 535.7 Million USD | -7.08% |
| 2008 FY | 2.12 Billion USD | 54.42% |
| 2008 Q1 | 489.8 Million USD | 16.45% |
| 2007 Q1 | 463.7 Million USD | -13.21% |
| 2007 Q2 | 512.1 Million USD | 10.44% |
| 2007 Q3 | -9.8 Million USD | -101.91% |
| 2007 FY | 1.37 Billion USD | -30.15% |
| 2007 Q4 | 420.6 Million USD | 4391.84% |
| 2006 Q1 | 372.4 Million USD | -25.53% |
| 2006 FY | 1.96 Billion USD | 11.57% |
| 2006 Q4 | 534.3 Million USD | -4.49% |
| 2006 Q3 | 559.4 Million USD | 15.48% |
| 2006 Q2 | 484.4 Million USD | 30.08% |
| 2005 Q3 | 584.2 Million USD | 82.11% |
| 2005 Q2 | 320.8 Million USD | -11.26% |
| 2005 Q1 | 361.5 Million USD | -35.8% |
| 2005 FY | 1.76 Billion USD | -24.58% |
| 2005 Q4 | 500.1 Million USD | -14.4% |
| 2004 Q2 | 587.3 Million USD | 12.42% |
| 2004 Q1 | 522.4 Million USD | -9.2% |
| 2004 Q3 | 664.5 Million USD | 13.14% |
| 2004 FY | 2.33 Billion USD | 4.26% |
| 2004 Q4 | 563.1 Million USD | -15.26% |
| 2003 FY | 2.24 Billion USD | 22.25% |
| 2003 Q4 | 575.3 Million USD | -5.41% |
| 2003 Q1 | 467.5 Million USD | -0.68% |
| 2003 Q2 | 590.9 Million USD | 26.4% |
| 2003 Q3 | 608.2 Million USD | 2.93% |
| 2002 Q4 | 470.7 Million USD | -4.6% |
| 2002 Q3 | 493.4 Million USD | 5.05% |
| 2002 Q2 | 469.7 Million USD | 17.43% |
| 2002 Q1 | 400 Million USD | -6.32% |
| 2002 FY | 1.83 Billion USD | 23.31% |
| 2001 Q4 | 427 Million USD | 22.03% |
| 2001 Q2 | 363.6 Million USD | 17.18% |
| 2001 Q3 | 349.9 Million USD | -3.77% |
| 2001 Q1 | 310.3 Million USD | -10.01% |
| 2001 FY | 1.48 Billion USD | 18.05% |
| 2000 Q1 | 263.5 Million USD | -7.54% |
| 2000 Q4 | 344.8 Million USD | 0.0% |
| 2000 FY | 1.25 Billion USD | 23.07% |
| 2000 Q3 | 344.8 Million USD | 12.46% |
| 2000 Q2 | 306.6 Million USD | 16.36% |
| 1999 Q2 | 173.3 Million USD | 21.27% |
| 1999 Q3 | 278.1 Million USD | 60.47% |
| 1999 Q4 | 285 Million USD | 2.48% |
| 1999 FY | 1.02 Billion USD | 116.09% |
| 1999 Q1 | 142.9 Million USD | 8.26% |
| 1998 Q2 | 113.7 Million USD | 27.75% |
| 1998 Q4 | 132 Million USD | -3.79% |
| 1998 FY | 473.7 Million USD | 21.06% |
| 1998 Q1 | 89 Million USD | -17.67% |
| 1998 Q3 | 137.2 Million USD | 20.67% |
| 1997 Q4 | 108.1 Million USD | -5.18% |
| 1997 Q3 | 114 Million USD | 25.14% |
| 1997 Q1 | 70.6 Million USD | -40.67% |
| 1997 Q2 | 91.1 Million USD | 29.04% |
| 1997 FY | 391.3 Million USD | 38.76% |
| 1996 Q1 | 38.4 Million USD | -12.13% |
| 1996 Q3 | 66.8 Million USD | 25.09% |
| 1996 Q2 | 53.4 Million USD | 39.06% |
| 1996 Q4 | 119 Million USD | 78.14% |
| 1996 FY | 282 Million USD | 72.27% |
| 1995 Q4 | 43.7 Million USD | -12.95% |
| 1995 Q1 | 31.2 Million USD | 991.43% |
| 1995 Q3 | 50.2 Million USD | 29.72% |
| 1995 Q2 | 38.7 Million USD | 24.04% |
| 1995 FY | 163.7 Million USD | 90.35% |
| 1994 FY | 86 Million USD | 45.76% |
| 1994 Q1 | 16.4 Million USD | 11.56% |
| 1994 Q3 | 36.9 Million USD | 97.33% |
| 1994 Q2 | 18.7 Million USD | 14.02% |
| 1994 Q4 | -3.5 Million USD | -109.49% |
| 1993 Q1 | 12.4 Million USD | -6.06% |
| 1993 FY | 59 Million USD | 24.47% |
| 1993 Q4 | 14.7 Million USD | -23.04% |
| 1993 Q3 | 19.1 Million USD | 34.51% |
| 1993 Q2 | 14.2 Million USD | 14.52% |
| 1992 Q2 | 12.4 Million USD | 34.78% |
| 1992 Q3 | 16.8 Million USD | 35.48% |
| 1992 FY | 47.4 Million USD | 36.6% |
| 1992 Q1 | 9.2 Million USD | 3.37% |
| 1992 Q4 | 13.2 Million USD | -21.43% |
| 1991 Q2 | 9.2 Million USD | 17.95% |
| 1991 Q4 | 8.9 Million USD | -23.28% |
| 1991 Q1 | 7.8 Million USD | 27.87% |
| 1991 Q3 | 11.6 Million USD | 26.09% |
| 1991 FY | 34.7 Million USD | 39.92% |
| 1990 Q3 | 8.2 Million USD | 36.67% |
| 1990 FY | 24.8 Million USD | 36.26% |
| 1990 Q1 | 8.2 Million USD | -95.97% |
| 1990 Q4 | 6.1 Million USD | -25.61% |
| 1990 Q2 | 6 Million USD | -26.83% |
| 1989 FY | 18.2 Million USD | 40.0% |
| 1989 Q3 | -484 Million USD | -364.77% |
| 1989 Q2 | 182.8 Million USD | 137.77% |
| 1989 Q1 | -484 Million USD | -412.26% |
| 1989 Q4 | 203.3 Million USD | 142.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 1043.289% |
| Accuray Incorporated | 504 Thousand USD | -246526.984% |
| Align Technology, Inc. | 643.33 Million USD | -93.211% |
| Elevance Health Inc. | 133.96 Billion USD | 99.072% |
| AxoGen, Inc. | -21.46 Million USD | 5891.632% |
| Boston Scientific Corporation | 2.34 Billion USD | 46.948% |
| CVS Health Corporation | 13.74 Billion USD | 90.955% |
| Centene Corporation | 2.93 Billion USD | 57.577% |
| DaVita Inc. | 1.6 Billion USD | 22.447% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 87.088% |
| Hologic, Inc. | 970.2 Million USD | -28.118% |
| Humana Inc. | 4.01 Billion USD | 69.026% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -13.296% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -71.307% |
| Masimo Corporation | 136.5 Million USD | -810.623% |
| McKesson Corporation | 3.9 Billion USD | 68.202% |
| Patterson Companies, Inc. | 252.92 Million USD | -391.452% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | 1.506% |
| ResMed Inc. | 1.31 Billion USD | 5.826% |
| Henry Schein, Inc. | 615 Million USD | -102.114% |
| Teladoc Health, Inc. | -248.55 Million USD | 600.095% |
| Universal Health Services, Inc. | 1.17 Billion USD | -5.753% |
| Veeva Systems Inc. | 429.33 Million USD | -189.518% |
| Baxter International Inc. | 390 Million USD | -218.718% |
| Becton, Dickinson and Company | 2.11 Billion USD | 41.118% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 29.647% |
| Danaher Corporation | 5.38 Billion USD | 76.9% |
| Stryker Corporation | 3.88 Billion USD | 68.03% |
| Medtronic plc | 5.14 Billion USD | 75.836% |